APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ankle Joint Pain Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ankle Joint Pain Injection Industry Growth and Trends Forecast to 2032

Report ID 173964330122 December 2025106 pages

Choose your research edition.

Industry ResearchAnkle Joint Pain Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ankle Joint Pain Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Ankle Joint Pain Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ankle Joint Pain Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ankle Joint Pain Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Ankle Joint Pain Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ankle Joint Pain Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ankle Joint Pain Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ankle Joint Pain Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ankle Joint Pain Injection include Teva Pharmaceutical Industries, Sanofi S.A, Pfizer, Ferring Pharmaceuticals, Zimmer Biomet Holdings, Wright Medical Group N.V, Seikagaku Corporation, Flexion Therapeutics and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ankle Joint Pain Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ankle Joint Pain Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ankle Joint Pain Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ankle Joint Pain Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ankle Joint Pain Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ankle Joint Pain Injection Market by Company

Teva Pharmaceutical Industries

Sanofi S.A

Pfizer

Ferring Pharmaceuticals

Zimmer Biomet Holdings

Wright Medical Group N.V

Seikagaku Corporation

Flexion Therapeutics

Dr. Reddy's Laboratories

Chugai Pharmaceutical

Bioventus

Anika Therapeutics

Ankle Joint Pain Injection Segment by Type

Hyaluronic Acid Injections

Corticosteroid Injections

Platelet Rich Plasma Injections

Others

Ankle Joint Pain Injection Segment by Application

Hospital

Clinic

Others

Ankle Joint Pain Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ankle Joint Pain Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ankle Joint Pain Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ankle Joint Pain Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ankle Joint Pain Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ankle Joint Pain Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hyaluronic Acid Injections Table 2. Major Company of Corticosteroid Injections Table 3. Major Company of Platelet Rich Plasma Injections Table 4. Major Company of Others Table 5. Global Ankle Joint Pain Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Ankle Joint Pain Injection Sales by Type (2021-2026) & (k units) Table 7. Global Ankle Joint Pain Injection Sales Market Share in Volume by Type (2021-2026) Table 8. Global Ankle Joint Pain Injection Sales by Type (2021-2026) & (US$ Million) Table 9. Global Ankle Joint Pain Injection Sales Market Share in Value by Type (2021-2026) Table 10. Global Ankle Joint Pain Injection Price by Type (2021-2026) & (US$/unit) Table 11. Global Ankle Joint Pain Injection Sales by Type (2027-2032) & (k units) Table 12. Global Ankle Joint Pain Injection Sales Market Share in Volume by Type (2027-2032) Table 13. Global Ankle Joint Pain Injection Sales by Type (2027-2032) & (US$ Million) Table 14. Global Ankle Joint Pain Injection Sales Market Share in Value by Type (2027-2032) Table 15. Global Ankle Joint Pain Injection Price by Type (2027-2032) & (US$/unit) Table 16. North America Ankle Joint Pain Injection Sales by Type (2021-2026) & (k units) Table 17. North America Ankle Joint Pain Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Ankle Joint Pain Injection Sales by Type (2021-2026) & (k units) Table 19. Europe Ankle Joint Pain Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Ankle Joint Pain Injection Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Ankle Joint Pain Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Ankle Joint Pain Injection Sales by Type (2021-2026) & (k units) Table 23. Latin America Ankle Joint Pain Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Ankle Joint Pain Injection Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Ankle Joint Pain Injection Sales by Type (2021-2026) & (US$ Million) Table 26. Ankle Joint Pain Injection Industry Trends Table 27. Ankle Joint Pain Injection Industry Drivers Table 28. Ankle Joint Pain Injection Industry Opportunities and Challenges Table 29. Ankle Joint Pain Injection Industry Restraints Table 30. Global Ankle Joint Pain Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Ankle Joint Pain Injection Revenue Market Share by Company (2021-2026) Table 32. Global Ankle Joint Pain Injection Sales by Company (2021-2026) & (k units) Table 33. Global Ankle Joint Pain Injection Sales Share by Company (2021-2026) Table 34. Global Ankle Joint Pain Injection Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Ankle Joint Pain Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Ankle Joint Pain Injection Major Company Production Sites and Headquarters Table 37. Global Ankle Joint Pain Injection Company, Product Type & Application Table 38. Global Ankle Joint Pain Injection Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Ankle Joint Pain Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Ankle Joint Pain Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Ankle Joint Pain Injection Sales by Region (2021-2026) & (k units) Table 43. Global Ankle Joint Pain Injection Sales Market Share in Volume by Region (2021-2026) Table 44. Global Ankle Joint Pain Injection Sales by Region (2021-2026) & (US$ Million) Table 45. Global Ankle Joint Pain Injection Sales Market Share in Value by Region (2021-2026) Table 46. Global Ankle Joint Pain Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Ankle Joint Pain Injection Sales by Region (2027-2032) & (k units) Table 48. Global Ankle Joint Pain Injection Sales Market Share in Volume by Region (2027-2032) Table 49. Global Ankle Joint Pain Injection Sales by Region (2027-2032) & (US$ Million) Table 50. Global Ankle Joint Pain Injection Sales Market Share in Value by Region (2027-2032) Table 51. Global Ankle Joint Pain Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Ankle Joint Pain Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Ankle Joint Pain Injection Sales by Application (2021-2026) & (k units) Table 54. Global Ankle Joint Pain Injection Sales Market Share in Volume by Application (2021-2026) Table 55. Global Ankle Joint Pain Injection Sales by Application (2021-2026) & (US$ Million) Table 56. Global Ankle Joint Pain Injection Sales Market Share in Value by Application (2021-2026) Table 57. Global Ankle Joint Pain Injection Price by Application (2021-2026) & (US$/unit) Table 58. Global Ankle Joint Pain Injection Sales by Application (2027-2032) & (k units) Table 59. Global Ankle Joint Pain Injection Sales Market Share in Volume by Application (2027-2032) Table 60. Global Ankle Joint Pain Injection Sales by Application (2027-2032) & (US$ Million) Table 61. Global Ankle Joint Pain Injection Sales Market Share in Value by Application (2027-2032) Table 62. Global Ankle Joint Pain Injection Price by Application (2027-2032) & (US$/unit) Table 63. North America Ankle Joint Pain Injection Sales by Application (2021-2026) & (k units) Table 64. North America Ankle Joint Pain Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Ankle Joint Pain Injection Sales by Application (2021-2026) & (k units) Table 66. Europe Ankle Joint Pain Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Ankle Joint Pain Injection Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Ankle Joint Pain Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Ankle Joint Pain Injection Sales by Application (2021-2026) & (k units) Table 70. Latin America Ankle Joint Pain Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Ankle Joint Pain Injection Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Ankle Joint Pain Injection Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries Company Information Table 74. Teva Pharmaceutical Industries Business Overview Table 75. Teva Pharmaceutical Industries Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Ankle Joint Pain Injection Product Portfolio Table 77. Teva Pharmaceutical Industries Recent Development Table 78. Sanofi S.A Company Information Table 79. Sanofi S.A Business Overview Table 80. Sanofi S.A Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi S.A Ankle Joint Pain Injection Product Portfolio Table 82. Sanofi S.A Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Pfizer Ankle Joint Pain Injection Product Portfolio Table 87. Pfizer Recent Development Table 88. Ferring Pharmaceuticals Company Information Table 89. Ferring Pharmaceuticals Business Overview Table 90. Ferring Pharmaceuticals Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Ferring Pharmaceuticals Ankle Joint Pain Injection Product Portfolio Table 92. Ferring Pharmaceuticals Recent Development Table 93. Zimmer Biomet Holdings Company Information Table 94. Zimmer Biomet Holdings Business Overview Table 95. Zimmer Biomet Holdings Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Zimmer Biomet Holdings Ankle Joint Pain Injection Product Portfolio Table 97. Zimmer Biomet Holdings Recent Development Table 98. Wright Medical Group N.V Company Information Table 99. Wright Medical Group N.V Business Overview Table 100. Wright Medical Group N.V Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Wright Medical Group N.V Ankle Joint Pain Injection Product Portfolio Table 102. Wright Medical Group N.V Recent Development Table 103. Seikagaku Corporation Company Information Table 104. Seikagaku Corporation Business Overview Table 105. Seikagaku Corporation Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Seikagaku Corporation Ankle Joint Pain Injection Product Portfolio Table 107. Seikagaku Corporation Recent Development Table 108. Flexion Therapeutics Company Information Table 109. Flexion Therapeutics Business Overview Table 110. Flexion Therapeutics Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Flexion Therapeutics Ankle Joint Pain Injection Product Portfolio Table 112. Flexion Therapeutics Recent Development Table 113. Dr. Reddy's Laboratories Company Information Table 114. Dr. Reddy's Laboratories Business Overview Table 115. Dr. Reddy's Laboratories Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Dr. Reddy's Laboratories Ankle Joint Pain Injection Product Portfolio Table 117. Dr. Reddy's Laboratories Recent Development Table 118. Chugai Pharmaceutical Company Information Table 119. Chugai Pharmaceutical Business Overview Table 120. Chugai Pharmaceutical Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Chugai Pharmaceutical Ankle Joint Pain Injection Product Portfolio Table 122. Chugai Pharmaceutical Recent Development Table 123. Bioventus Company Information Table 124. Bioventus Business Overview Table 125. Bioventus Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Bioventus Ankle Joint Pain Injection Product Portfolio Table 127. Bioventus Recent Development Table 128. Anika Therapeutics Company Information Table 129. Anika Therapeutics Business Overview Table 130. Anika Therapeutics Ankle Joint Pain Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Anika Therapeutics Ankle Joint Pain Injection Product Portfolio Table 132. Anika Therapeutics Recent Development Table 133. North America Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. North America Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 135. North America Ankle Joint Pain Injection Sales Market Share by Country (2021-2026) Table 136. North America Ankle Joint Pain Injection Sales Forecast by Country (2027-2032) & (k units) Table 137. North America Ankle Joint Pain Injection Sales Market Share Forecast by Country (2027-2032) Table 138. North America Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Ankle Joint Pain Injection Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Ankle Joint Pain Injection Market Share by Country (2021-2026) Table 141. North America Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Ankle Joint Pain Injection Market Share Forecast by Country (2027-2032) Table 143. Europe Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Europe Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 145. Europe Ankle Joint Pain Injection Sales Market Share by Country (2021-2026) Table 146. Europe Ankle Joint Pain Injection Sales Forecast by Country (2027-2032) & (k units) Table 147. Europe Ankle Joint Pain Injection Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Ankle Joint Pain Injection Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Ankle Joint Pain Injection Market Share by Country (2021-2026) Table 151. Europe Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Ankle Joint Pain Injection Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 155. Asia-Pacific Ankle Joint Pain Injection Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Ankle Joint Pain Injection Sales Forecast by Country (2027-2032) & (k units) Table 157. Asia-Pacific Ankle Joint Pain Injection Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Ankle Joint Pain Injection Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Ankle Joint Pain Injection Market Share by Country (2021-2026) Table 161. Asia-Pacific Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Ankle Joint Pain Injection Market Share Forecast by Country (2027-2032) Table 163. Latin America Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Latin America Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 165. Latin America Ankle Joint Pain Injection Sales Market Share by Country (2021-2026) Table 166. Latin America Ankle Joint Pain Injection Sales Forecast by Country (2027-2032) & (k units) Table 167. Latin America Ankle Joint Pain Injection Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Ankle Joint Pain Injection Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Ankle Joint Pain Injection Market Share by Country (2021-2026) Table 171. Latin America Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Ankle Joint Pain Injection Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 175. Middle East and Africa Ankle Joint Pain Injection Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Ankle Joint Pain Injection Sales Forecast by Country (2027-2032) & (k units) Table 177. Middle East and Africa Ankle Joint Pain Injection Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Ankle Joint Pain Injection Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Ankle Joint Pain Injection Market Share by Country (2021-2026) Table 181. Middle East and Africa Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Ankle Joint Pain Injection Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Ankle Joint Pain Injection Distributors List Table 186. Ankle Joint Pain Injection Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Ankle Joint Pain Injection Image Figure 2. Global Ankle Joint Pain Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ankle Joint Pain Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ankle Joint Pain Injection Sales (2021-2032) & (k units) Figure 5. Hyaluronic Acid Injections Image Figure 6. Global Hyaluronic Acid Injections Sales YoY Growth (2021-2032) & (k units) Figure 7. Corticosteroid Injections Image Figure 8. Global Corticosteroid Injections Sales YoY Growth (2021-2032) & (k units) Figure 9. Platelet Rich Plasma Injections Image Figure 10. Global Platelet Rich Plasma Injections Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Ankle Joint Pain Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Ankle Joint Pain Injection Market Share by Type 2025 VS 2032 Figure 15. North America Ankle Joint Pain Injection Sales Market Share in Volume by Type in 2025 Figure 16. North America Ankle Joint Pain Injection Sales Market Share in Value by Type in 2025 Figure 17. Europe Ankle Joint Pain Injection Sales Market Share in Volume by Type in 2025 Figure 18. Europe Ankle Joint Pain Injection Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Ankle Joint Pain Injection Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Ankle Joint Pain Injection Sales Market Share in Value by Type in 2025 Figure 21. Latin America Ankle Joint Pain Injection Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Ankle Joint Pain Injection Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Ankle Joint Pain Injection Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Ankle Joint Pain Injection Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Ankle Joint Pain Injection Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Ankle Joint Pain Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Ankle Joint Pain Injection Market Share by Application 2025 VS 2032 Figure 35. North America Ankle Joint Pain Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Ankle Joint Pain Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Ankle Joint Pain Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Ankle Joint Pain Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Ankle Joint Pain Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Ankle Joint Pain Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Ankle Joint Pain Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Ankle Joint Pain Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Ankle Joint Pain Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Ankle Joint Pain Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Ankle Joint Pain Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Ankle Joint Pain Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Ankle Joint Pain Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Ankle Joint Pain Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ankle Joint Pain Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Ankle Joint Pain Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ankle Joint Pain Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Ankle Joint Pain Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Ankle Joint Pain Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Ankle Joint Pain Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ankle Joint Pain Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Ankle Joint Pain Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ankle Joint Pain Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Ankle Joint Pain Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ankle Joint Pain Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Ankle Joint Pain Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Ankle Joint Pain Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Ankle Joint Pain Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ankle Joint Pain Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Ankle Joint Pain Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ankle Joint Pain Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Ankle Joint Pain Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hyaluronic Acid Injections
  • Corticosteroid Injections
  • Platelet Rich Plasma Injections
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi S.A
  • Pfizer
  • Ferring Pharmaceuticals
  • Zimmer Biomet Holdings
  • Wright Medical Group N.V
  • Seikagaku Corporation
  • Flexion Therapeutics
  • Dr. Reddy's Laboratories
  • Chugai Pharmaceutical
  • Bioventus
  • Anika Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ankle Joint Pain Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ankle Joint Pain Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ankle Joint Pain Injection Market by Type
  6. 1.3.1 Hyaluronic Acid Injections
  7. 1.3.2 Corticosteroid Injections
  8. 1.3.3 Platelet Rich Plasma Injections
  9. 1.3.4 Others
  10. 1.4 Global Ankle Joint Pain Injection Market Size by Type
  11. 1.4.1 Global Ankle Joint Pain Injection Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Ankle Joint Pain Injection Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Ankle Joint Pain Injection Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Ankle Joint Pain Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Ankle Joint Pain Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Ankle Joint Pain Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Ankle Joint Pain Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Ankle Joint Pain Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ankle Joint Pain Injection Industry Trends
  2. 2.2 Ankle Joint Pain Injection Industry Drivers
  3. 2.3 Ankle Joint Pain Injection Industry Opportunities and Challenges
  4. 2.4 Ankle Joint Pain Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ankle Joint Pain Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Ankle Joint Pain Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Ankle Joint Pain Injection Price (2021-2026)
  4. 3.4 Global Ankle Joint Pain Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ankle Joint Pain Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Ankle Joint Pain Injection Company, Product Type & Application
  7. 3.7 Global Ankle Joint Pain Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ankle Joint Pain Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ankle Joint Pain Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ankle Joint Pain Injection Tier 1, Tier 2, and Tier 3
4 Ankle Joint Pain Injection Regional Status and Outlook
  1. 4.1 Global Ankle Joint Pain Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ankle Joint Pain Injection Historic Market Size by Region
  3. 4.2.1 Global Ankle Joint Pain Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ankle Joint Pain Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ankle Joint Pain Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ankle Joint Pain Injection Forecasted Market Size by Region
  7. 4.3.1 Global Ankle Joint Pain Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ankle Joint Pain Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ankle Joint Pain Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ankle Joint Pain Injection by Application
  1. 5.1 Ankle Joint Pain Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Ankle Joint Pain Injection Market Size by Application
  6. 5.2.1 Global Ankle Joint Pain Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ankle Joint Pain Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ankle Joint Pain Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ankle Joint Pain Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ankle Joint Pain Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ankle Joint Pain Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ankle Joint Pain Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ankle Joint Pain Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ankle Joint Pain Injection Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Sanofi S.A
  8. 6.2.1 Sanofi S.A Company Information
  9. 6.2.2 Sanofi S.A Business Overview
  10. 6.2.3 Sanofi S.A Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi S.A Ankle Joint Pain Injection Product Portfolio
  12. 6.2.5 Sanofi S.A Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Ankle Joint Pain Injection Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Ferring Pharmaceuticals
  20. 6.4.1 Ferring Pharmaceuticals Company Information
  21. 6.4.2 Ferring Pharmaceuticals Business Overview
  22. 6.4.3 Ferring Pharmaceuticals Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ferring Pharmaceuticals Ankle Joint Pain Injection Product Portfolio
  24. 6.4.5 Ferring Pharmaceuticals Recent Developments
  25. 6.5 Zimmer Biomet Holdings
  26. 6.5.1 Zimmer Biomet Holdings Company Information
  27. 6.5.2 Zimmer Biomet Holdings Business Overview
  28. 6.5.3 Zimmer Biomet Holdings Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zimmer Biomet Holdings Ankle Joint Pain Injection Product Portfolio
  30. 6.5.5 Zimmer Biomet Holdings Recent Developments
  31. 6.6 Wright Medical Group N.V
  32. 6.6.1 Wright Medical Group N.V Company Information
  33. 6.6.2 Wright Medical Group N.V Business Overview
  34. 6.6.3 Wright Medical Group N.V Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wright Medical Group N.V Ankle Joint Pain Injection Product Portfolio
  36. 6.6.5 Wright Medical Group N.V Recent Developments
  37. 6.7 Seikagaku Corporation
  38. 6.7.1 Seikagaku Corporation Company Information
  39. 6.7.2 Seikagaku Corporation Business Overview
  40. 6.7.3 Seikagaku Corporation Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Seikagaku Corporation Ankle Joint Pain Injection Product Portfolio
  42. 6.7.5 Seikagaku Corporation Recent Developments
  43. 6.8 Flexion Therapeutics
  44. 6.8.1 Flexion Therapeutics Company Information
  45. 6.8.2 Flexion Therapeutics Business Overview
  46. 6.8.3 Flexion Therapeutics Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Flexion Therapeutics Ankle Joint Pain Injection Product Portfolio
  48. 6.8.5 Flexion Therapeutics Recent Developments
  49. 6.9 Dr. Reddy's Laboratories
  50. 6.9.1 Dr. Reddy's Laboratories Company Information
  51. 6.9.2 Dr. Reddy's Laboratories Business Overview
  52. 6.9.3 Dr. Reddy's Laboratories Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr. Reddy's Laboratories Ankle Joint Pain Injection Product Portfolio
  54. 6.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 6.10 Chugai Pharmaceutical
  56. 6.10.1 Chugai Pharmaceutical Company Information
  57. 6.10.2 Chugai Pharmaceutical Business Overview
  58. 6.10.3 Chugai Pharmaceutical Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chugai Pharmaceutical Ankle Joint Pain Injection Product Portfolio
  60. 6.10.5 Chugai Pharmaceutical Recent Developments
  61. 6.11 Bioventus
  62. 6.11.1 Bioventus Company Information
  63. 6.11.2 Bioventus Business Overview
  64. 6.11.3 Bioventus Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bioventus Ankle Joint Pain Injection Product Portfolio
  66. 6.11.5 Bioventus Recent Developments
  67. 6.12 Anika Therapeutics
  68. 6.12.1 Anika Therapeutics Company Information
  69. 6.12.2 Anika Therapeutics Business Overview
  70. 6.12.3 Anika Therapeutics Ankle Joint Pain Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Anika Therapeutics Ankle Joint Pain Injection Product Portfolio
  72. 6.12.5 Anika Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Ankle Joint Pain Injection Sales by Country
  2. 7.1.1 North America Ankle Joint Pain Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ankle Joint Pain Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Ankle Joint Pain Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ankle Joint Pain Injection Market Size by Country
  6. 7.2.1 North America Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ankle Joint Pain Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ankle Joint Pain Injection Sales by Country
  2. 8.1.1 Europe Ankle Joint Pain Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ankle Joint Pain Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Ankle Joint Pain Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ankle Joint Pain Injection Market Size by Country
  6. 8.2.1 Europe Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ankle Joint Pain Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ankle Joint Pain Injection Sales by Country
  2. 9.1.1 Asia-Pacific Ankle Joint Pain Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ankle Joint Pain Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ankle Joint Pain Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ankle Joint Pain Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ankle Joint Pain Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ankle Joint Pain Injection Sales by Country
  2. 10.1.1 South America Ankle Joint Pain Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ankle Joint Pain Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Ankle Joint Pain Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ankle Joint Pain Injection Market Size by Country
  6. 10.2.1 South America Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ankle Joint Pain Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ankle Joint Pain Injection Sales by Country
  2. 11.1.1 Middle East and Africa Ankle Joint Pain Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ankle Joint Pain Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ankle Joint Pain Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ankle Joint Pain Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Ankle Joint Pain Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ankle Joint Pain Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ankle Joint Pain Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ankle Joint Pain Injection Value Chain Analysis
  2. 12.1.1 Ankle Joint Pain Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ankle Joint Pain Injection Production Mode & Process
  7. 12.2 Ankle Joint Pain Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ankle Joint Pain Injection Distributors
  10. 12.2.3 Ankle Joint Pain Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst